EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Luminescence of favipiravir in skin appendages and sclera. A controlled study and literature review

Deniz Demircioğlu iD, Emel Öztürk Durmaz iD

Photodermatology, Photoimmunology & Photomedicine · 2024

DOI: 10.1111/phpp.12919 ↗

At a glance

Übersichtsarbeit in Photodermatology, Photoimmunology & Photomedicine, 2024. Written by Deniz Demircioğlu and 1 co-authors. Institution: Department of Dermatology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, Istanbul, Turkey. Major MEDLINE topics: Luminescence, COVID-19, Amides, Pyrazines. 27 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background/Objectives Favipiravir is an antiviral agent, recently used for COVID‐19 infections. Several reports associate favipiravir intake with Wood's lamp fluorescence of hair, nails, and sclera. The present study was designed to elucidate the positivity rates, and sites of favipiravir‐related fluorescence and to unravel the site‐specific changes in fluorescence positivity rates by a function of time past exposure.

Methods

The study population comprised 50 patients and 50 control individuals. All patients in the patient group had received a full dose of favipiravir for COVID‐19 infection. Fifty volunteers served as the control group. Wood's lamp examination was performed in a completely darkened room, and the positivity rate, extent, pattern, and distribution of fluorescence were recorded.

Results

Wood's light revealed fluorescence of the fingernails, toenails, sclera, and hair in 35 (70%), 35 (70%), 22 (44%), and 8 (16%) patients, respectively. No control individual tested positive by Wood's lamp. Statistical analysis revealed significant differences between patient and control groups in terms of Wood's light luminescence in the fingernails ( p = .000), toenails ( p = .000), sclera ( p = .000) and hair ( p = .003). Although fingernail, toenail, and hair fluorescence positivity rates declined or ceased at or after 91 days of favipiravir exposure, ocular fluorescence positivity rates were prolonged up to 188 days.

Conclusions

These findings confirm that favipiravir may produce fluorescence of nails, sclera, and hair, detectable by Wood's light starting from the initial month and peaking at second‐ and third months following exposure to the medication. Although nail and hair fluorescence tend to abate after 3 months, ocular fluorescence may persist even longer than 6 months after cessation of the medication.

Subjects

MeSH terms (MEDLINE)

LuminescenceCOVID-19AmidesPyrazinesHumansScleraUltraviolet Rays

Author keywords

COVID-19UV lampWood's lightconjunctivacoronavirusfavipiravirferric oxidefluorescencehairluminescencenailpolyvinylpyrrolidoneteethtitanium dioxide

Substances

favipiravirAmidesPyrazines

Authors and institutions

  • Department of Dermatology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, Istanbul, Turkey.

ORCID profiles: Deniz Demircioğlu, Emel Öztürk Durmaz

Cite

APA

Demircioğlu, D., & Durmaz, E. Ö. (2024). Luminescence of favipiravir in skin appendages and sclera. A controlled study and literature review. Photodermatology, Photoimmunology & Photomedicine. https://doi.org/10.1111/phpp.12919

Vancouver

Demircioğlu D, Durmaz EÖ. Luminescence of favipiravir in skin appendages and sclera. A controlled study and literature review. Photodermatology, Photoimmunology & Photomedicine. 2024. doi:10.1111/phpp.12919

BibTeX
@article{Demirciolu2024,
  author = {Demircioğlu, Deniz and Durmaz, Emel Öztürk},
  title = {Luminescence of favipiravir in skin appendages and sclera. A controlled study and literature review},
  journal = {Photodermatology, Photoimmunology & Photomedicine},
  year = {2024},
  doi = {10.1111/phpp.12919}
}
Start for free →